SuperworthJourney Medical market cap DERM
Share price times shares outstanding: what the whole company sells for, since 2021.
- Today, Oct 23, 2026
- $141.7M
- Highest close in our data
- $235.5M
- Jan 2026
Journey Medical is worth $141.7M at the close on Oct 23, 2026, at $5.02 a share.
That is down 22% over the last year and up 22% over five years.
Its highest close in our data was $235.5M in Jan 2026.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $141.7M | $125.2M | $235.5M | −34% |
| 2025 | $214.9M | $76.5M | $222.1M | +147% |
| 2024 | $87.1M | $61.1M | $135.3M | −18% |
| 2023 | $106.6M | $19.2M | $147.3M | +214% |
| 2022 | $34M | $20.9M | $92.3M | −62% |
| 2021 | $89.6M | $89.6M | $116.3M | n/a |
Against its peers
Companies in Drug Manufacturers - General nearest Journey Medical's size, closest first, today.
| Company | Market cap |
|---|---|
| DERMJourney Medical | $141.7M |
| NATRNatures Sunshine Products | $213.8M |
| LFVNLifevantage | $73.4M |
| SPROSpero Therapeutics | $64.6M |
| ATNMActinium Pharmaceuticals | $47.8M |
| ARVNArvinas | $477.3M |
| PBYIPuma Biotechnology | $568.9M |
| IRWDIronwood Pharmaceuticals | $571.7M |
| ZVRAZevra Therapeutics | $582.6M |
| CRMDCorMedix | $611.9M |
| COLLCollegium Pharmaceutical | $747.5M |
| Peer median | $523.1M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Journey Medical
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.